Episode #65: Identifying High-Risk Barrett’s Esophagus Patients | Lisa Mathew & Raman Muthusamy | UCLA School of Medicine
Update: 2024-10-09
Description
Dr. Lisa Mathew interviews Dr. Raman Muthusamy, professor of clinical medicine at the David Geffen School of Medicine at UCLA, and medical director of endoscopy for UCLA Health, about a new clinical guideline for endoscopic eradication therapy to prevent the progression of Barrett’s esophagus to esophageal cancer.
Esophageal cancer is preventable if high-risk patients, such as those with Barrett’s Esophagus, are treated with endoscopic eradication therapy to eliminate the Barrett’s tissue.
Endoscopic eradication therapy is highly effective, but the challenge is identifying the high-risk patients to treat and the low-risk patients for whom long-interval surveillance may be appropriate.
Join Dr. Mathew and Dr. Muthusamy as they explore new technologies for identifying patients who are most at risk and the potential innovations that could stop a majority of Barrett’s Esophagus patients from progressing to esophageal cancer.
---
Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC
Mixed and mastered by Hayden Margolis
Gastro Broadcast, Episode 65, presented by TissueCypher from Castle Biosciences
Esophageal cancer is preventable if high-risk patients, such as those with Barrett’s Esophagus, are treated with endoscopic eradication therapy to eliminate the Barrett’s tissue.
Endoscopic eradication therapy is highly effective, but the challenge is identifying the high-risk patients to treat and the low-risk patients for whom long-interval surveillance may be appropriate.
Join Dr. Mathew and Dr. Muthusamy as they explore new technologies for identifying patients who are most at risk and the potential innovations that could stop a majority of Barrett’s Esophagus patients from progressing to esophageal cancer.
---
Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC
Mixed and mastered by Hayden Margolis
Gastro Broadcast, Episode 65, presented by TissueCypher from Castle Biosciences
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
